| Name | Title | Contact Details |
|---|---|---|
Dean Schultz |
Chief Information Security Officer | Profile |
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
Temrex Corp is a Freeport, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CME was founded in 1978 by psychiatrist John Schwartz, whose vision was to provide high-quality, practical continuing medical education and information for mental health clinicians throughout the United States. In its first decade, CME successfully
Dudnyk Healthcare Group is a Horsham, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
TriRivers Health Partners is a Rockford, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.